Distinct t(7;9)(q34;q32) breakpoints in healthy individuals and individuals with T-ALL
- 3 February 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 33 (3), 342-344
- https://doi.org/10.1038/ng1092
Abstract
After V(D)J-mediated translocations, signal joints are retained on one of the derivative chromosomes. We report here that such signal joints are highly reactive and constitute unstable genomic elements with potential oncogenic properties.Keywords
This publication has 13 references indexed in Scilit:
- Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemiaCancer Cell, 2002
- V(D)J-mediated Translocations in Lymphoid Neoplasms: A Functional Assessment of Genomic Instability by Cryptic SitesThe Journal of Experimental Medicine, 2002
- Analysis of the V(D)J Recombination Efficiency at Lymphoid Chromosomal Translocation BreakpointsJournal of Biological Chemistry, 2001
- Control of V(D)J Recombinational Accessibility of the Dβ1 Gene Segment at the TCRβ Locus by a Germline PromoterImmunity, 1999
- Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.The EMBO Journal, 1996
- The role of chromosome translocations in T cell acute leukemiaCurrent Opinion in Immunology, 1995
- Chromosomal translocations in human cancerNature, 1994
- TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia.Proceedings of the National Academy of Sciences, 1991
- Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia.The Journal of Experimental Medicine, 1991
- Consistent breakage between consensus recombinase heptamers of chromosome 9 DNA in a recurrent chromosomal translocation of human T cell leukemia.The Journal of Experimental Medicine, 1989